Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am
Ribonucleic acid-based therapy for enhancing memory and cognition: LncRNA DIGIT increases Tissue inhibitor of metalloproteinases 2 (TIMP2) levels, improves cognition, and decreases age-associated decline in memory and learning, via down-regulation of its target genes, 23/January/2019, 11.41 am
Spread the love
Spread the love
Let's have a chat!
Sign-up for our newsletter to learn more about upcoming Genomediscovery Forums!